OncoCyte Corporation, a developer of novel tests for the early diagnosis and management of lung cancer, today announced the successful completion of the CLIA Validation study of DetermaDx (previously...
Read More »OncoCyte tees up for lung cancer liquid biopsy launch
Fierce Biotech – OncoCyte, which is developing blood-based tests to catch cancer early, announced Monday that its lung cancer diagnostic succeeded in a 300-patient study. The company plans to launch the test in the second half of this year. The ...
Read More »